Loading...
Loading...
Contributors:
Dataset URI:
10.6084/m9.figshare.34050553.v1Hypertension remains a leading contributor to cardiovascular mortality worldwide. However, integrated surveillance frameworks linking epidemiological burden, healthcare performance, and clinical outcomes remain limited. This study aimed to characterize hypertension epidemiology and management in Portuguese primary health care using real-world evidence from publicly-available indicators. A retrospective ecological (aggregated group-level) study was conducted, using the five Portuguese mainland administrative health regions and the country as the units of analysis, with data obtained from Portuguese primary health care information systems from 2021–2025. Temporal and regional trends in hypertension prevalence and incidence, blood pressure (BP) monitoring and control, cardiovascular risk assessment, therapeutic review, prescribing patterns, and composite management indicators were assessed across the five mainland Portuguese administrative health regions. A multidisciplinary expert panel provided structured clinical appraisal of indicator relevance and interpretability. Hypertension prevalence and incidence increased nationally over time, with persistent regional heterogeneity. The Norte region showed consistently higher performance across monitoring and control indicators, whereas Algarve and Alentejo exhibited generally poorer results. BP monitoring and control improved across all regions, with the proportion of hypertensive adults aged 18-64 years, with BP Hypertension management indicators in Portuguese primary care improved substantially between 2021 and 2025; however, regional disparities and methodological limitations remain. Current monitoring frameworks provide valuable real-world insights but incompletely capture clinically meaningful outcomes, supporting the need for more outcome-directed systems. What is the context: Hypertension is a major cardiovascular risk factor, and monitoring its management across Portugal's primary care system helps assess annual trends and regional difference. What is new: Between 2021–2025, hypertension prevalence rose slightly nationwide, particularly in Alentejo, although blood pressure control improved substantially across all regions, with Norte showing the strongest gains. What is the impact: Improved primary care hypertension indicators may reflect progress in disease management, changes in coding or recording practices, or both. Future efforts should prioritize standardized blood pressure documentation and linkage of primary care, hospital, and cardiovascular outcomes data, enabling outcome-oriented surveillance that can guide health policies into addressing regional inequalities, and contributing to measurable improvements in morbidity and mortality.
Keyword(s):
Biotechnology; Blood pressure; Environmental Sciences not elsewhere classified; Epidemiology; Health systems research.
MeSH Term(s):
Grants and Funding:
No Grants or Funding Data Available
Associated Publication(s):
Supplementary Data:
No Supplementary Data Available
Related Dataset(s):
No Related Dataset Data Available
The National Library of Medicine (NLM) provides information about biomedical datasets. Inclusion on an NLM Web page does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: NLM Web Policies (nih.gov)